Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop.

Source:http://linkedlifedata.com/resource/pubmed/id/8823310

J. Clin. Invest. 1996 Sep 15 98 6 1441-8

Download in:

View as

General Info

PMID
8823310